Not Signed In -
Dutasteride |
Avodart |
Dutasteride Systematic (IUPAC) name ? Identifiers CAS number 164656-23-9 ATC code G04CB02 PubChem 152945 DrugBank APRD00385 Chemical data Formula C27H30F6N2O2 Mol. weight 528.53 g/mol Pharmacokinetic data Bioavailability ? Protein binding 99% Metabolism ? Half life 5 weeks Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status Routes ? Dutasteride (marketed as Avodart®, Avidart®, Avolve®, Duage ...
Wikipedia - [full article]
Dutasteride Clinical Trials
- Dutasteride to Treat Women with Menstrually Related Mood Disorders
ClinicalTrials.gov Identifier: NCT00082043 - Recruiting
Premenstrual Syndrome
- 28-Day Study of Testosterone Co-Administered With Dutasteride in Hypogonadal Men
ClinicalTrials.gov Identifier: NCT00398580 - Active, not recruiting
Hypogonadism
- Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
ClinicalTrials.gov Identifier: NCT00274417 - Active, not recruiting
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
- A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
ClinicalTrials.gov Identifier: NCT00431626 - Recruiting
Benign Prostatic Hyperplasia
- Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
ClinicalTrials.gov Identifier: NCT00363311 - Active, not recruiting
Prostate Cancer
- Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
ClinicalTrials.gov Identifier: NCT00403000 - Active, not recruiting
Prostate Cancer
- Testosterone Replacement and Dutasteride Effectiveness (TRADE) Study
ClinicalTrials.gov Identifier: NCT00194675 - Recruiting
Hypogonadism; Benign Prostatic Hyperplasia
- Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
ClinicalTrials.gov Identifier: NCT00062790 - Completed
Benign Prostatic Hyperplasia
- Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
Benign Prostatic Hyperplasia
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
ClinicalTrials.gov Identifier: NCT00368979 - Active, not recruiting
Benign Prostatic Hyperplasia
- Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
ClinicalTrials.gov Identifier: NCT00303446 - Active, not recruiting
Kennedy's Disease; Spinal and Bulbar Muscular Atrophy
- Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00553878 - Recruiting
Prostate Cancer
- Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00244309 - Recruiting
Prostate Cancer
- Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
ClinicalTrials.gov Identifier: NCT00382356 - Recruiting
Benign Prostatic Hypertrophy
- A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
ClinicalTrials.gov Identifier: NCT00441116 - Recruiting
Androgenetic Alopecia
- Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
ClinicalTrials.gov Identifier: NCT00398281 - Recruiting
Prostate Cancer
- Dutasteride and Androgen-Ablation Therapy in Treating Patients With Localized Prostate Cancer Who Have Undergone Radiation Therapy and/or Surgery
ClinicalTrials.gov Identifier: NCT00516815 - Recruiting
Prostate Cancer
- Testosterone and Its Metabolites in GID
ClinicalTrials.gov Identifier: NCT00146146 - Recruiting
Transsexualism
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
ClinicalTrials.gov Identifier: NCT00527605 - Not yet recruiting
Benign Prostatic Hyperplasia
- Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
ClinicalTrials.gov Identifier: NCT00400335 - Completed
Hypogonadism
- Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
ClinicalTrials.gov Identifier: NCT00421421 - Terminated
Benign Prostatic Hyperplasia
Resources
- Avodart (Drug Digest)
- Avodart Consumer Information (U.S. Food and Drug Administration)
email this page
print this page
bookmark this page
feedback on this page
